Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity and diabetes drugs. January 14, 2025
